FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Biologics

FDA Official Pushes Back in UniQure Dispute

A senior FDA official sharply criticizes UniQures investigational gene therapy for Huntington's disease, calling it a failed product and casting doubt...

latest-news-card-1
Medical Devices

Attorneys Review FDAs New Inspection Approach for Devices

Ropes & Gray attorneys Joshua Oyster and Austin Laroche review in a WestLaw Today article FDAs new inspection approach for medical device manufacturer...

latest-news-card-1
Human Drugs

Senate Committee Has More Drug Supply Questions

Bipartisan leaders of the Senate Select Committee on Aging ask CVS, Walgreens, and Walmart for additional information on their efforts to protect the ...

latest-news-card-1
Medical Devices

Petition Asks FDA to Investigate Mayo Robotic Mastectomy

Harmed Americans for Reform in Medical Device Safety petitions FDA to investigate the Mayo Clinics use of a robotic mastectomy device.

latest-news-card-1
FDA General

FDA Operations Chief Announces Retirement

FDA deputy commissioner for operations and chief operating officer Barclay Butler announces his retirement in the coming months.

latest-news-card-1
Human Drugs

FDA Approves Teclistamab Combination for Multiple Myeloma

FDA approves Janssen Biotechs Tecvayli (teclistamab) in combination with Darzalex Faspro (daratumumab hyaluronidase-fihj) for certain adult patients w...

latest-news-card-1
Human Drugs

Regulate Outsourcing Ophthalmic Bevacizumab Products: Petition

A Buchanan petition asks FDA to take administrative and enforcement action against 503B outsourcing facilities that are marketing ophthalmic bevacizum...

latest-news-card-1
Human Drugs

Breakthrough Status for Hemabs Bleeding Disorder Therapy

FDA grants Hemab Therapeutics a breakthrough therapy designation for sutacimig, an experimental therapy being developed to prevent bleeding episodes i...

Animal Drugs

Partial Hold on Myotonic Dystrophy Type 1 Therapy

FDA places a partial clinical hold on a mid-stage U.S. trial of PepGen Inc.s experimental therapy for myotonic dystrophy Type 1.

latest-news-card-1
FDA General

FDA Overhauls National Drug Codes

FDA finalizes a sweeping overhaul of the National Drug Code system, adopting a standardized 12-digit format for the identifier used to uniquely distin...